| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 Mar 2025 | 26 Mar 2025 |
| Outcome of The Separate Meeting Of Independent Directors Of The Company Held On Wednesday, March 26, 2025. | ||
| Board Meeting | 17 Mar 2025 | 17 Mar 2025 |
| Conversion of 17,04,661 warrants into 17,04,661 equity shares of face value of Rs. 10/- each This is to inform you that we are hereby rectified the inadvertent clerical/typographical error in the Annexure A Disclosure under Outcome of Board Meeting of the Company held on March 17, 2025 for Conversion of 17,04,661 warrants into 17,04,661 equity shares of face value of Rs. 10/- each (As Per BSE Announcement Dated on: 22/03/2025) | ||
| Board Meeting | 10 Mar 2025 | 10 Mar 2025 |
| Conversion of 15,75,666 warrants into 15,75,666 equity shares of face value of Rs. 10/- each | ||
| Board Meeting | 3 Feb 2025 | 29 Jan 2025 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve Un-Audited Financial Result for the Quarter and Nine Month ended on 31.12.2024 Outcome of Board Meeting held on 03.02.2025 (As Per BSE Announcement Dated on: 03/02/2025) | ||
| Board Meeting | 27 Dec 2024 | 27 Dec 2024 |
| Conversion of 2,08,333 warrants into 2,08,333 equity shares of face value of Rs. 10/- each | ||
| Board Meeting | 23 Dec 2024 | 23 Dec 2024 |
| Outcome of Board Meeting of the Company held on Monday, December 23, 2024 | ||
| Board Meeting | 11 Nov 2024 | 11 Nov 2024 |
| Board meeting outcome held on November 11, 2024 | ||
| Board Meeting | 23 Oct 2024 | 19 Oct 2024 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the proposal to raise funds. Outcome of Board Meeting 23.10.2024 (As per BSE Announcement Dated on 23/10/2024) | ||
| Board Meeting | 12 Oct 2024 | 8 Oct 2024 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2024 inter alia to consider and approve the Unaudited standalone financial results of the Company for the quarter ended on September 30 2024. The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2024. (As Per BSE Announcement on 12-10-2024) | ||
| Board Meeting | 21 Aug 2024 | 21 Aug 2024 |
| Outcome of Board Meeting held on 21.08.2024 | ||
| Board Meeting | 18 Jul 2024 | 13 Jul 2024 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2024 inter alia to consider and approve un-audited standalone financial results of the Company for the quarter ended June 30 2024: The Board Meeting to be held on 17/07/2024 has been revised to 18/07/2024 The Board Meeting to be held on 17/07/2024 has been revised to 18/07/2024. (As per BSE Announcement Dated on 16/07/2024) Outcome of Board Meeting held on today-July 18, 2024. Financial Result for the Quarter ended June 30, 2024. (As per BSE Announcement Dated on 18/07/2024) | ||
| Board Meeting | 25 May 2024 | 13 May 2024 |
| Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve including Audited Standalone Financial Result for the Quarter and Financial Year Ended on 31st March 2024. Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 ,inter alia, to consider and approve Including the Audited Standalone Financial Result for the Quarter and Financial Year Ended on 31st March, 2024. (As Per BSE Announcement Dated on 20/05/2024) The Board of Directors has approved and taken on record the Audited Standalone Financial Results of the Company for the Financial Year ended March 31, 2024. The Board of Directors has approved and taken on record the Audited Standalone Financial Results of the Company for the Financial Year ended March 31, 2024 The Board Recommended to the Members the re-appointment of M/ s. Shah Kailash & Associates LLP, Chartered Accountants as the Statutory Auditor of the Company for the second term of from the conclusion of the ensuing 16th Annual General Meeting till the conclusion of 19th Annual General Meeting of the Company. The Board of Directors inter-alia has approved the Appointment of M/s. Purushottam Khandelwal & Co., Chartered Accountant having FRN No. 123825W as an Internal Auditor for the financial year 2024-25. The Board of Directors has approved the Appointment of Amareliya & Associates, Practicing Company Secretary as a Secretarial Auditor for the financial year 2024-25. (As Per BSE Announcement Dated on 25.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
